The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akshay Bansarilal Arora
BLUEJET · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Smallcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Akshay Bansarilal Arora, a promoter of Blue Jet Healthcare, sold 1,07,34,529 equity shares (6.19% of paid-up capital) through an Offer for Sale on the stock exchanges on September 10-11, 2025. Before the sale, he held 11,96,70,324 shares (68.99%); after the sale, his holding stands at 10,88,35,795 shares (62.80%). The OFS was conducted under SEBI's OFS guidelines, with shares allocated to non-retail investors on T day and to retail investors on T+1 day. This is a significant reduction in promoter stake, though he remains the majority holder with over 60% of the company.
A 6.19% promoter share sale is sizeable and could weigh on short-term sentiment as supply increases in the market. However, since this was executed through the structured OFS mechanism, it provides transparency and price discovery. Shareholders should note that promoter holding, while reduced, remains comfortably above the 50% mark at 62.80%.